• Japanese
  • Korean
  • Chinese
Cover Image

Blood Banking And Blood Products

Product Description

This report analyzes the worldwide markets for Blood Banking and Blood Products in US$ Million by the following Product Segments: Blood Components and Plasma Products (Whole Blood & Cellular Components, & Plasma Fractions), and Equipment, Blood Tests and Other Consumables (Includes blood screening and related QC function, but excludes patient diagnosis). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 228 companies including leading blood banks such as AABB, America's Blood Centers, American Red Cross, Canadian Blood Services, Japan Red Cross, National Blood Foundation, and New York Blood Center. Some of the leading players in Blood Bank Technology & Supplies also discussed in this report include Beckman Coulter Inc., Becton Dickinson and Company, BioMerieux SA, Caridian BCT, Inc., Chiron, CSL Behring LLC, Daxor Corporation, Fenwal Inc., Gen-Probe, Inc., Haemonetics Corp, Hemagen Diagnostics Inc., Immucor Inc., Kawasumi Laboratories, Inc., Novartis Vaccines and Diagnostics, Inc., Terumo Corporation, Terumo BCT Inc., ThermoGenesis Corp., and Velico Medical, Inc. Leading Players discussed under the Plasma Fractionation segment include Baxter International Inc., Beijing Tiantan Biological Products Co., Ltd., Bharat Serums, Bio Products Laboratory, Biotest AG, CSL Limited, Grifols, S.A, Guizhou Taibang Biological Products Co., Ltd., Huanlan Biological Engineering Inc., Kedrion S.p.A., Laboratoire Francais du Fractionnement et des Biotechnologies, Octapharma AG, OMRIX Biopharmaceuticals Ltd., Shanghai RAAS Blood Products Co., Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., and Sanquin. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

  • Quantitative Techniques & Analytics

Product Definitions and Scope of Study

  • Blood Components and Plasma Products
    • Whole Blood & Cellular Components
      • WBCs
      • RBCs
      • Platelets
    • Plasma Fractions
      • Fresh Frozen Plasma
      • Albumin Fractions
      • Factor VIII
      • Factor IX and Factor IX Complex
      • Fibrin/Thrombin
  • Equipment, Blood Tests and Consumables
    • Automated Analyzers for Blood Analysis
    • Blood Tests
    • Consumables

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Healthcare Scares Propel the Market
  • Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts
  • Worldwide Blood Banking and Blood Products Market at a Glance (All figures are 2012 estimates & CAGR is for the period 2010-2018)
  • Current and Future Analysis
  • Analysis by Geographic Region
  • Analysis by Product Segment
  • World Blood Components and Plasma Market Analysis in Units
    • Table 1: World Recent Past, Current & Future Analysis for Blood Components and Plasma by Region/Country - US, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 2: World 9-Year Perspective for Blood Components and Plasma by Region/Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World Markets for Years 2010, 2012 & 2018 (includes corresponding Graph/Chart)
  • Red Blood Cells - A Key Blood Component and a Major Contributor
    • Table 3: World Recent Past, Current & Future Analysis for Red Blood Cells by Region/Country - US, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 4: World 9-Year Perspective for Red Blood Cells by Region/Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World Markets for Years 2010, 2012 & 2018 (includes corresponding Graph/Chart)
  • Blood Plasma Derivatives: An Overview
  • Blood Plasma Sourcing
  • Plasma Derived Products: Production
    • IVIG
    • Factor VIII
    • Albumin
  • Costs Associated with Plasma Derivatives Production
    • Table 5: Global Plasma Derivatives Market: Percentage Breakdown of Costs Associated with Production (includes corresponding Graph/Chart)
  • Player Scenario
    • Table 6: Global Plasma Derived Products Market (2011): Percentage Share Breakdown by Leading Players - Baxter, CSL, Grifols (incl. Talecris), Octapharma, LFB, Biotest, Kedrion and Others (includes corresponding Graph/Chart)
    • Table 7: Global IVIg Market (2011): Percentage Breakdown of Market Share for Leading Players (includes corresponding Graph/Chart)
    • Indications Addressed by Major Global IVIg Manufacturers
    • Table 8: Comparative Costs between Plasma Protein Therapies and Artificially Synthesized Pharmaceuticals (includes corresponding Graph/Chart)
    • Table 9: Global Plasma Market in the Recent Past (2008): Market Shares of CSL Behring and Talecris in Select Plasma Product Markets in terms of Revenues (includes corresponding Graph/Chart)
  • Competitive Landscape across Blood Banking, Blood Derived Products and Plasma Production
    • Table 10: Leading Players in the Global Blood Screening Market (2011) (includes corresponding Graph/Chart)
    • Table 11: Global Blood Derivatives Production (2011): Percentage Share Breakdown of Leading Players - Baxter, CSL, Grifols (incl. Talecris), Octapharma, Novo Nordisk, Bayer, Pfizer, Non-Profit Organizations, and Others (includes corresponding Graph/Chart)
    • Table 12: Global Blood Plasma Manufacturing Market (2011): Percentage Share Breakdown by Leading Players - Baxter, CSL, Grifols (incl. Talecris), Pfizer, Novo Nordisk and Others (includes corresponding Graph/Chart)
  • Withdrawal of Octapharma's IVIG Proves Advantageous to Competitors

2. MARKET TRENDS & ISSUES

  • Key Trends in Blood Banking/Pre-Transfusion Diagnostics
  • Demand Exceeds Supply: Self-Sufficiency is the New Mantra
  • PrIME: An Innovative High-Yield Process to Address Supply Dearth
  • Present State of Plasma Fractionating Industry
  • Plasma Fractionation Industry Concentrated in Developed Countries
  • PrIME Tackles the Issue of Currently Unprocessable Plasma
  • New Infections - A Continuous Threat
  • Safety and Availability: The Core Issues
  • Decontamination: A Viable Process
  • New Processes for Safer Blood Supply
  • Diagnostic Innovative Procedures Help Blood Conservation
  • Autologous Transfusion Strapping up for High Growth
  • Enzyme Converted Cells Set to Rule the Industry
  • Blood Unavailability: Substitutes to the Rescue
  • Transfusions: Hospitals Making Way for Others
  • Computer Identification Helps Patients
  • SARS: A Case of Mistaken Identity?
  • Pooling: Economical HIV Testing
  • Private Cord Blood Banking: Flying High Despite Opposition
  • Automation of Blood Banking - Nearing the Efficiency Frontier?
  • Automated Instrumentation Taking the Front Seat
    • Table 13: World Market for Blood Bank Technology (2011): Percentage Breakdown of Revenues by Segment - Manual Blood Bag Systems, Automated Systems, Component Lab, Commercial Plasma, Blood Salvage, and Pathogen Inactivation (includes corresponding Graph/Chart)
  • Plasma Market: Automation Making Inroads
  • The RBC Market - Slow to Catch Up
  • Automation of Testing - Yet to Mature
  • Automation to Suffice Shortage Problems
  • How Near to the Efficiency Frontier?

3. PRODUCT OVERVIEW

  • Blood Banking and Blood Products Industry
  • Blood Components and Plasma Products
  • Equipment, Blood Tests and Consumables
    • Automated Analyzers for Blood Analysis
    • Blood Tests
    • Consumables
      • Blood Collection Equipment
      • Blood Collection Monitors
      • Blood Donor Couches
      • Blood Processing Equipment
      • Blood Bank Centrifuges
      • Plasma Thawing
      • Blood Cell Separators
      • Blood Storage Equipment
      • Blood Bags
      • Platelet Agitators
      • Blood Bank Refrigerators
  • Blood - A Primer
  • Ionic Structure
    • Blood Components and their Applications
  • Blood Constituents
  • Plasma
  • Red Blood Cells (RBC)
    • Blood Count
  • Platelets
  • White Blood Cells (WBC)
  • Derivative Products of Blood or Plasma Fractions
  • Plasma Protein and Fractionation
    • Plasma Fractionation: Origins and Development
    • Table 14: Plasma Fractionation Processes: Comparison of Cohn IVIG and PrIME IVIG Based on Specific Characteristics
    • The Need
    • Fresh Frozen Plasma
    • Other Plasma Fractions
  • Albumin Fractions
    • Albumin Usage Rising in Profile, Wastage Worries Run Deep
  • Immunoglobulins
    • Immunoglobulin Products Available in the Market (2012)
    • Table 15: Leading Countries in IVIg Usage Rates in Grams per 1000 Population (includes corresponding Graph/Chart)
  • Hyper-Immune Immunoglobulin
  • Factor VIII
  • Factor IX and Factor IX Complex
  • Fibrin/Thrombin
    • Consumption of Blood Based on Type of Surgery/Accident (In Units)
    • Table 16: World Market for Plasma Derivatives (2011): Percentage Breakdown of Revenues by Product Type - IVIG, Albumin, vWFactor & pdFVIII, Hyperimmunes, A1PI, Poly IG and Others (includes corresponding Graph/Chart)
  • Recombinant Products
    • Development Pipeline of Select rFVIII Products for Hemophilia A Therapy: Breakdown by Product Name, Developing Company, State of Development and Expected Market Launch
    • Table 17: Global Market for Recombinant Hemophilia Therapy (2011): Percentage Share Breakdown for Leading Players (includes corresponding Graph/Chart)
  • Therapeutic Uses of Plasma Products
  • Albumin Products
  • Immunoglobulins
    • Intravenous Immunoglobulin (IVIg)
    • Normal Immunoglobulin (IMIg)
    • CMV Immunoglobulin
    • Hepatitis B Immunoglobulin
    • Rh (D) Immunoglobulin
    • Tetanus Immunoglobulin IM
    • Zoster Immunoglobulin
    • Table 18: Global Market for Immunoglobulins (IG) (2012): Percentage Share Breakdown of Leading Products (includes corresponding Graph/Chart)
  • Plasma Derived Coagulant Products
    • Biostate(r)
    • Ceprotin(r)
    • Factor VII Concentrate
    • Factor XI Concentrates
    • Feiba VH(r) Inhibitor Treatment
    • Fibrogammin P(r)
    • Monofix(r)-VF
    • ProthrombinexTM-HT
    • Thrombotrol(r)-VF

4. BLOOD COLLECTION METHODS

  • Banking the Natural Blood Resources
  • Blood Banks
  • Blood Banking
  • Blood Transfusion
  • Role of Blood Banks
  • Blood Donor: The Epicenter of the Process
  • Eligibility Criteria for the Donor
  • The Basics of Blood Donation - Myths Exploded & Other Facts
    • Table 19: Active Donors of Whole Blood and Apheresis per 1,000 of Population by Country/ Agency (includes corresponding Graph/Chart)
    • Table 20: Percentage Breakdown of Apheresis and Whole Blood Donations by Country (includes corresponding Graph/Chart)
  • Collection Methods
  • Blood Donation: The Process
    • Types of Blood Donation
      • Directed Blood Donations
      • Autologous Blood Donation
      • Alternative Usage of Patient's Own Blood
      • General Blood Donation
      • Hemodilution
      • Wound Drainage
      • Cell Saver
    • The Method
  • Blood Salvaging
  • Blood Collection Centers
    • Blood Collection Management System
      • A Historical Retrospective
      • Blood Collection Centers
    • Types of Blood Collection Centers
      • Cord Blood Banks
      • Profit Collection Centers
      • Military Blood Banks
      • Hospital Blood Banks
      • Community Blood Banks
      • Non-Profit Collection Centers
  • Blood Processing
    • Blood Typing
      • Rh Blood Group System
      • ABO Blood Group System
      • Blood Types and their Compatibility
    • Table 21: Occurrence of Blood Groups Worldwide (In %) (includes corresponding Graph/Chart)
    • Blood Test
    • Blood Culture
  • The Costs
  • History of Blood Banking

5. THE CHANGING LANDSCAPE OF TRANSFUSION TECHNOLOGIES & TESTS

  • Blood Transfusion: A Backdrop
  • Massive Transfusion
  • Complications and Risks Due to Transfusion
  • Circulatory Overload
  • Graft Versus Host Disease (GVHD)
  • Hemolytic Transfusion Reactions
  • Iron Overload
  • Bacterial Contamination
  • Thrombophlebitis
  • Allergic Reactions
  • Air Embolism
  • Hyperkalaemia
  • Changing Role of Blood Banking Technology

6. BLOOD TRANSFUSION: THE PROCESS, TESTS/TECHNOLOGIES

  • Cross Matching
  • Blood Donor/Recipient Screening
  • Blood Typing
  • Leukoreduction
  • Leukocyte Reduction Specification Standards/Filters
  • Coombs Test

7. ALTERNATIVES TO BLOOD TRANSFUSION: A REAL THREAT TO THE INDUSTRY

  • Bloodless Surgery
  • Therapeutic Apheresis
  • Plasmapheresis
  • Plateletpheresis
  • Leukapheresis
  • Volume Expanders
  • Colloids
    • Albumin
    • Dextrans
    • Hydroxyethyl Starch
  • Crystalloids
  • Blood Growth Factor Therapies - Newer Alternatives to Transfusion

8. BLOOD SUBSTITUTES

  • Blood Substitutes Under Development by Manufacturers
  • Synthetic Blood Manufacturers/Developers
  • Alliance Pharmaceuticals Corp. (US)
  • Biopure Corporation (US)
  • Enzon Pharmaceuticals (US)
  • Hemosol Inc. (Canada)
  • Northfield Laboratories Inc. (US)
  • Synthetic Blood International, Inc. (US)

9. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST - A PERSPECTIVE BUILDER

  • America's Blood Centers Launches Management System for Blood Products
  • Biomatrica Introduces DNAstable(r) Blood and DNAgard(r) Blood for Whole Blood Stabilization at Room Temperature
  • Bio-Rad Launches Fully-Automated IH 1000 Blood Screening System
  • Fenwal Receives US FDA Clearance for Fenwal Amicus(r) Separator System
  • BD Unveils BD Microtainer(r) MAP Microtube
  • Pall Releases Advanced Blood Filter
  • CaridianBCT Rolls Out RBCX Protocol
  • ITL Launches TEGO(tm) Animal Blood Collection Kit
  • Fenwal to Launch Modified ALYX Kit
  • QIAGEN Launches New QIAsafe DNA Blood Products
  • Gambro Introduces New Prismaflex eXeed(tm) System
  • AnaSpec Unveils 'SensoLyte(r) Rh110 Plasmin Activity Assay Kit
  • Typenex(r) Medical Rolls Out New Barcode Blood Band
  • Olympus Introduces Hemoglobin A1c APT Reagent for Chemistry Analyzer System
  • BD Diagnostics Launches BD BACTEC(tm) FX Blood Culture System
  • Beckman Coulter Launches UniCel DxH 800 Coulter(r) Cellular Analysis System

10. PRODUCT APPROVALS

  • Quotient Receives FDA Approval for ALBAcyte Reagent RBC Products
  • EMIT Wins FDA Market Approval for Hypotherm X HX100 Device
  • MedPro Blood Collection Safety Products Obtain CE Mark
  • Huaren Pharmaceutical GI and PD Solutions Obtain SFDA Approval
  • Cerus INTERCEPT Blood System Obtains Approval from Swissmedic
  • Abbott Obtains BLA Clearance from FDA for ABBOTT PRISM Chagas Test
  • CaridianBCT Obtains FDA Approval for New 6.0 Trima Accel(r) Automated Blood Collection System
  • FDA Grants 510(K) Clearance for Expanded Use of Haemonetics
  • Fenwal Secures FDA Approval for New Platelet Additive Solution
  • BD Diagnostics Bags FDA Approval for BD Vacutainer(r) Rapid Serum Tube
  • Abbott Obtains FDA Approval for Abbott Prism HIV O Plus Test

11. PRODUCT APPROVALS IN THE RECENT PAST

  • Cerus Receives CE Mark Approval for the INTERCEPT Blood System for Platelets
  • Haemonetics Wins FDA Approval for the ACP 215 System
  • Biomerieux' Polycarbonate BacT/ALERT Receives US FDA Clearance
  • Pall's eBDS Receives Green Signal from FDA
  • CardioPAT(tm) Surgical Blood Salvage System
  • PCS(r) 2 - Set to Enhance Plasma Quality
  • Dade Behring's D-Dimer Assay Strapping up for Roll Out

12. RECENT INDUSTRY ACTIVITY

  • Hologic to Take Over Gen-Probe
  • ProMetic Obtains New Purchase under Octapharma Agreement
  • Grifols Takes Over Talecris
  • IVD Acquisition Acquires Immucor
  • Nordson Takes Over Value Plastics
  • American Red Cross Takes Over RBC Collection Assets of HemaCare
  • Terumo Acquires CaridianBCT
  • Bioniche to Take Over Plasvacc
  • Logic Management Consulting to Take Over Guiyang Dalin Biologic Technologies
  • Humanwell Healthcare Acquires Further Stake in Zhongyuan Ruide Bio
  • Red Cross and Mitsubishi Tanabe to Combine Plasma Fractionation Business
  • Fenwal Signs Definitive Agreement with Golden Meditech to Set Up JV
  • Fenwal and Biolog-id Enter into Marketing Agreement
  • GE Healthcare and Neste Jacobs Enter into Partnership
  • Cerus Enters into Supply Agreement with Etablissement Francais du Sang
  • Transfusion Management Services and Vedant Enter into Partnership
  • Global Healing Collaborates with Partners in Health
  • ProMetic Expands Strategic Partnership with WIBP
  • Amunix Partners with Biogen Idec
  • Fenwal and GenesisBPS Ink Agreement for Blood-Specialty Products
  • Remi Enters into Collaboration with Barkey for Indian Market
  • Huaren Pharma to Set Up R&D Center for Blood Purification
  • China Biologic to Commence Commercial Collection of Plasma at Ninyang
  • Grifols to Construct Plasma Fractionation Plant
  • HLL Lifecare Inaugurates Second Blood Bag Plant in India

13. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER

  • Pall Inks Distribution Agreement with ASI
  • Cerus Inks Deal with Swiss Red Cross for Deploying INTERCEPT Blood System
  • PT Bio Farma to Construct New Albumin Plant in Indonesia
  • NACO to Establish Plasma Fractionation Facility in Chennai
  • Improve Medical Instruments to Establish Subsidiary in Beijing
  • China Biologic Products Obtains License for Plasma Collection from Shandong Province Health Department
  • Sorin Group Sells Two Non-Core Product Lines to Cytomedix
  • Sigma to Lease QC Manager Software to New Orleans based Blood Center
  • CaridianBCT's PRT System Chosen by Polish Health Ministry
  • Micronics Obtains FDA Approval to Market ABORhCard
  • HemaCare Signs Two New Blood Service Contracts
  • Haemonetics Gains Rights to Alba's Full Line of Blood Typing Reagents
  • American Red Cross Inks 3-Year Deal with ITL
  • Daxor's Idant Labs Bags Blood Banking Contract from RMSB&G
  • Beckman Coulter Agrees to Distribute CellaVision Digital Morphology Products
  • Haemonetics Takes Over Global Med
  • Therapure Biopharma Inks Long Term Pact with LFB Biomedicaments
  • MRHC Obtains License for SafeTrace Tx Solution of Global Med
  • Life Technologies to Acquire AcroMetrix
  • Heska Enters into a Supply Agreement with Roche Diagnostics
  • BLOOD Bank of Alaska Obtains License for Mediware's LifeTrak Technology
  • Europe and the US Expand Blood Banking Agreement
  • Pfizer Acquires Wyeth
  • Baxter Inaugurates New BLOOD Plasma Fractionation Facility in Vienna
  • ProMetic Acquires Majority Shareholding in PRDT
  • China Biologic to Collaborate with IBT on Research & Development
  • Gen-Probe to Establish Independent New Firm for Industrial Testing
  • Haemonetics Acquires SEBRA Blood Collection & Processing Unit
  • Beckman Coulter Acquires Lab Based Diagnostics Business of Olympus
  • Golden Meditech and Fenwal to Establish a Blood Collection Joint Venture in China
  • PRCS Inaugurates State-of-the-Art Blood Bank
  • CSL and Talecris Terminate Merger Agreement
  • Immucor Inks 5-Year Deal with Alverno
  • Gen-Probe Acquires Tepnel and Renews Partnership with Novartis
  • Haemonetics Takes Over Neoteric Technology
  • Haemonetics Acquires Altivation Software
  • PacifiCord Sets Up Cord Blood Banking Facility in Irvine
  • China Biologic Acquires 35% Stake in Xi`an Huitian Blood Products
  • Octapharma Plans to Set Up Fractionation Facility in Poland
  • Therapure BioPharma Inks Development Services Deal with LFB Biotechnologies
  • Biotest Acquires Blood Plasma Collection Center from Talecris
  • Gen-Probe Expands and Extends Blood Screening Alliance with Novartis
  • Celestial Biologicals Collaborates with GE Healthcare for Indian Market

14. FOCUS ON SELECT GLOBAL PLAYERS

  • Leading Blood Banks
  • AABB (US)
  • America's Blood Centers (US)
  • American Red Cross (US)
  • Canadian Blood Services (Canada)
  • Japan Red Cross Society (Japan)
  • National Blood Foundation (US)
  • New York Blood Center (US)
  • Leading Players in Blood Bank Technology and Supplies
  • Beckman Coulter, Inc. (US)
  • Becton, Dickinson and Company (US)
  • BioMerieux SA (France)
  • CSL Behring LLC (US)
  • Daxor Corporation (US)
  • Fenwal Inc. (US)
  • Gen-Probe, Inc. (US)
  • Haemonetics Corporation (US)
  • Hemagen Diagnostics Inc. (US)
  • Immucor Inc. (US)
  • Kawasumi Laboratories, Inc. (Japan)
  • Novartis Vaccines and Diagnostics, Inc (US)
  • Terumo Corp. (Japan)
    • Terumo BCT Inc (US)
  • ThermoGenesis Corp. (US)
  • Velico Medical, Inc. (US)
  • Leading Players in Plasma Fractionation
  • Baxter International Inc. (US)
  • Beijing Tiantan Biological Products Co., Ltd (China)
  • Bharat Serums and Vaccines Ltd (India)
  • Bio Products Laboratory Ltd (UK)
  • Biotest AG (Germany)
  • CSL Limited (Australia)
  • Grifols, S.A (Spain)
  • Guizhou Taibang Biological Products Co., Ltd (China)
  • Huanlan Biological Engineering Inc. (China)
  • Kedrion S.p.A. (Italy)
  • Laboratoire Francais du Fractionnement et des Biotechnologies (France)
  • Octapharma AG (Switzerland)
  • OMRIX Biopharmaceuticals Ltd (Israel)
  • Shanghai RAAS Blood Products Co., Ltd. (China)
  • Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd (China)
  • Sanquin (The Netherlands)

15. GLOBAL MARKET PERSPECTIVE

    • Table 22: World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 23: World Historic Review for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 24: World 15-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
  • Blood Banking and Blood Products Market by Product Group/Segment
    • Table 25: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 26: World Historic Review for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 27: World 15-Year Perspective for Blood Components and Plasma Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 28: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Product Segment - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 29: World Historic Review for Blood Components and Plasma Products by Product Segment - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 30: World 15-Year Perspective for Blood Components and Plasma Products by Product Segment - Percentage Breakdown of Value Sales for Whole Blood & Cellular Components, and Plasma Fractions Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 31: World Recent Past, Current & Future Analysis for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 32: World Historic Review for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 33: World 15-Year Perspective for Whole Blood & Cellular Components by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 34: World Recent Past, Current & Future Analysis for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 35: World Historic Review for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 36: World 15-Year Perspective for Plasma Fractions by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 37: World Recent Past, Current & Future Analysis for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 38: World Historic Review for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 39: World 15-Year Perspective for Equipment, Blood Tests and Other Consumables by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current and Future Analysis
    • Table 40: Blood and Organ Banks in the US (2011): Percentage Share Breakdown of Revenues for Major Players - American Red Cross, Musculoskeletal Transplant Foundation Inc., Community Blood Center and Community Tissue Services and CSL Ltd. (includes corresponding Graph/Chart)
    • Table 41: US Blood Bank Industry (2011): Percentage Share Breakdown by Major Blood Suppliers (includes corresponding Graph/Chart)
    • Market Trends
      • Recession Impacts Blood Bank Reserves
      • US Blood Collection & Supply Profile
      • Blood Group Distribution
    • Table 42: US Market for Blood Banking and Blood Products: Percentage Break up of Blood Group by Rh Factor (includes corresponding Graph/Chart)
    • Table 43: Percentage Break up of Rh Blood Types in the US by Racial Group (includes corresponding Graph/Chart)
      • Blood Donated and Transfused Every Year
      • Males Form the Major Chunk of Donors
      • Cost of Blood
      • SARS Scares: Blood Banks Feel the Heat
    • Blood and Blood Preparations: A Review of Trade Statistics
    • Table 44: US Blood and Blood Preparations Market (2010 & 2011): Percentage Breakdown of Value Imports by Country of Origin for Germany, UK, Canada, Switzerland, Belgium and Others (includes corresponding Graph/Chart)
    • Table 45: US Blood and Blood Preparations Market (2010 & 2011): Percentage Breakdown of Value Exports by Destination for UK, Germany, Canada, Netherlands, Belgium and Others (includes corresponding Graph/Chart)
    • Table 46: US Market for Globulins (2011): Percentage Breakdown by Leading Players for Baxter, Grifols (incl. Talecris), CSL and Octapharma (includes corresponding Graph/Chart)
    • US Blood Components and Plasma Market Analysis in Units
    • Table 47: US Recent Past, Current & Future Analysis for Blood Components and Plasma by Product Category - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Million Units for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 48: US Historic Review for Blood Components and Plasma by Product Category - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Million Units for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 49: US 15-Year Perspective for Blood Components and Plasma by Product Category - Percentage Breakdown of Volume Consumption for Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Regulations Control Plasma Collection Industry
    • Product launch
    • Strategic Corporate Developments
    • Key players
  • B. Market Analytics
    • Table 50: US Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 51: US Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 52: US 15-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current and Future Analysis
    • Blood Facts
    • Bleeding Disorders - A Major Threat
    • 'CSA-Z902-04' - A Comprehensive Voluntary Blood Safety Standard
    • Blood and Blood Preparations: Import & Export Scenario
    • Table 53: Canadian Blood and Blood Preparations Market (2010 & 2011): Percentage Breakdown of Value Imports by Country of Origin for US, Switzerland, Germany, Netherlands, UK and Other Countries (includes corresponding Graph/Chart)
    • Table 54: Canadian Blood and Blood Preparations Market (2010 & 2011): Percentage Breakdown of Value Exports by Destination for US, France, UK, Japan, Australia and Other Countries (includes corresponding Graph/Chart)
    • Strategic Corporate Development
    • Canadian Blood Services - the Major Blood Bank
  • B. Market Analytics
    • Table 55: Canadian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 56: Canadian Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 57: Canadian 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current and Future Analysis
    • Japan Witnesses Surge in Imported Blood Products
    • Growing Market for Fresh Frozen Plasma
    • Growing Use of Imported Albumin Based Blood Products
    • The Goal of Self-Sufficiency
    • Strategic Corporate Development
    • Key players
  • B. Market Analytics
    • Table 58: Japanese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 59: Japanese Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 60: Japanese 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current and Future Analysis
      • European Blood Banking and Blood Products Market at a Glance (All figures are 2012 estimates & CAGR is for the period 2010-2018)
    • Market Trends and Issues
      • Legislations on Payment for Donation Restrict Donors
      • Government's Check on Healthcare Costs Pressurizes BCT Manufacturers
      • Purchasing System Witnesses Modifications
      • EU Nations Marching Towards Self-Sufficiency in Blood and Blood Products
    • Blood Banking Devices Market
    • Table 61: European Recent Past, Current & Future Analysis for Blood Banking Devices - Manual Blood Collection, Apheresis, and Autologous Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 62: European Historic Review for Blood Banking Devices - Manual Blood Collection, Apheresis, and Autologous Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 63: European 15-Year Perspective for Blood Banking Devices - Percentage Breakdown of Value Sales for Manual Blood Collection, Apheresis, and Autologous Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 64: European Blood Banking Devices Market (2012): Percentage Breakdown of Value Sales by Geographic Region for France, Germany, Italy, UK, Spain and Rest of Europe (includes corresponding Graph/Chart)
    • A Snapshot of Health Care Systems Across Select EU Countries
      • France
      • Germany
      • Italy
      • The UK
      • Spain
  • B. Market Analytics
    • Table 65: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 66: European Historic Review for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 67: European 15-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 68: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 69: European Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 70: European 15-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current and Future Analysis
    • Strategic Corporate Development
    • Key players
  • B. Market Analytics
    • Table 71: French Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 72: French Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 73: French 15-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current and Future Analysis
    • Biotest AG - A Key Player
  • B. Market Analytics
    • Table 74: German Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 75: German Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 76: German 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Current and Future Analysis
    • Kedrion S.p.A. - A Key Player
  • B. Market Analytics
    • Table 77: Italian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 78: Italian Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 79: Italian 15-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current and Future Analysis
    • Blood Requirements
    • Bio Products Laboratory Ltd - A Key Player
  • B. Market Analytics
    • Table 80: The UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 81: The UK Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 82: The UK 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Current and Future Analysis
    • Strategic Corporate Development
    • Grifols, S.A - A Key Player
  • B. Market Analytics
    • Table 83: Spanish Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 84: Spanish Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 85: Spanish 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4f. RUSSIA

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 86: Russian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 87: Russian Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 88: Russian 15-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • Denmark - High Participation and Consumption of Blood
    • Key players
  • B. Market Analytics
    • Table 89: Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 90: Rest of Europe Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 91: Rest of Europe 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
    • Overview of Select Regional Markets
      • ASEAN - Striding Towards Standardization of Blood Supply
      • China - A Key Market
      • Blood Collection Industry: A Snapshot of the Past
      • Blood Products Industry - An Overview
      • Performance Review
      • Chinese Blood Products Industry Poised for Expansion
    • Table 92: Blood Products Industry in China (2009 & 2011): Percentage Breakdown by Product Type for Albumin, IVIG, Coagulation Factor and Others (includes corresponding Graph/Chart)
      • Volume Declines but Revenues Shoot Up in Chinese Blood Products Market
      • Government Wakes Up to Realities
    • Table 93: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Group by Type - A, B, O, and AB (includes corresponding Graph/Chart)
    • Table 94: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Donor by Gender - Male and Female (includes corresponding Graph/Chart)
    • Table 95: Chinese Blood Banking and Blood Products Market: Percentage Breakdown of Blood Donor by Age Group - 16-20, 21-30, 31-40, 41-50, 51-60, and 61-70 (includes corresponding Graph/Chart)
      • Albumin Market in China Gains Favor of both Global and Local Players
    • Table 96: Albumin Market in China (2011): Percentage Share Breakdown by Leading Players - CSL, Octapharma, Baxter, Grifols, CBPO, Hualan Biological, Chengdu Rongsheng, Sichuan Yuanda, Green Cross and Others (includes corresponding Graph/Chart)
      • India
      • Blood Banking Equipment Market on the Rise
      • Tube Sealers and Blood Bags Dominate the Market
      • Recent Trends in the Market
      • Indian Blood Banking Market Witnesses Major Transformations
      • Market Growth - Influencing Factors
      • Increased Awareness Drives Voluntary Blood Donations in India
      • Competitive Scenario
      • Australia
      • National Blood Supply: An Overview
      • Role of National Blood Authority
      • Maintenance Expenditure on the Rise
      • Indonesia
    • Strategic Corporate Developments
    • Key players
  • B. Market Analytics
    • Table 97: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 98: Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 99: Asia-Pacific 15-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Current and Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 100: Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 101: Latin American Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 102: Latin American 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Current and Future Analysis
    • OMRIX Biopharmaceuticals Ltd (Israel) - A Key player
  • B. Market Analytics
    • Table 103: Rest of World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 104: Rest of World Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 105: Rest of World 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
Show More
Pricing